Antibodies for the treatment of autoimmune diseases that inhibit the secretion of IL-17

A new therapeutic mechanism to inhibit cytokine production from topical IL-17-producing cells by CD96 neutralizing antibodies

NF-κB inducing kinase (NIK) Novel target for cholangiocarcinoma

Molecular targeted drugs targeting the NIK associated with the differentiation factor from hepatocytes to cholangiocarcinoma

A new concept for the treatment of allergic dermatitis by targeting glycan receptors on macrophages

Inhibition of TLR4-dependent allergic inflammatory response by Asialoglycoprotein receptor (Asgr1) glycan ligands

IBD treatment by intestinal administration of human iPS cell-derived organoids

A mechanism for promoting intestinal tissue regeneration by direct administration of high-quality intestinal organoids with villi-crypt structure derived from human iPS cells into the intestine.

Ornithine/Arginine Nanoparticles for Suppressing Liver Damage in Hyperammonemia

Anti-CD155 antibody treatment for Th1 type autoimmune diseases

Treatment of immunological diseases by a new mechanism to control the immune Th1/Th2 balance

ASO Therapy for Solid Tumors

Antisense oligonucleotide (ASO) therapy for two independent targets, GREB1 and ARL4C genes.

Liver organoid model containing human hepatocytes for pharmacokinetic assay

Original method and hepatocyte reproduced hepatobiliary function

Highly Specific/Efficient Protein Linker

One Step N-Terminal Conjugation of Functional Compounds

Cell based therapy for vascular regeneration

Vascular endothelial stem cells (VESCs) based therapy is a promising approach for vascular regeneration.